A critical advance in cancer research is emerging with the use of mini-antibodies to re-engage dysfunctional p53. This vital malignant suppressor protein is frequently disabled in several kinds of malignancies, https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research